MDT logo
MDT@NYSE
Medtronic Plc
$ 88.48+0.73 (+0.83%)
Comprar MDT
AperturaPrecio de apertura
—
MínimoPrecio mínimo de hoy
—
Máximo de 52 semanasMáximo en 52 semanas
—
MáximoPrecio máximo de hoy
—
Mínimo de 52 semanasMínimo en 52 semanas
—
Cap. de mercadoValor total de la empresa
112.32B
Volumen de hoyAcciones negociadas hoy
105.66M
Volumen promedioPromedio de acciones negociadas
11.36M
Relación P/ERelación precio-beneficio
21.45

Perfil de la empresa

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Fecha de salida a bolsa
1973-05-02
Sede
Galway, IE
CEO
Geoffrey Straub Martha
Sector
Healthcare
Industria
Medical - Devices

Estados financieros

Resultados

Empresas relacionadas

688617.SS logo
688617.SSAPT Medical Inc.
242.85
AVR logo
AVRAnteris Technologies Global Corp.
6.77
BSX logo
BSXBoston Scientific Corporation
42.73
EW logo
EWEdwards Lifesciences Corporation
85.21

Desbloquea el futuro del trading

Acceso sin interrupciones a los mercados globales con información basada en inteligencia artificial para operar de forma más inteligente y segura.

Maqueta del dispositivo